Olstein Capital Management L.P. Lowers Stake in CVS Health Corporation $CVS

Olstein Capital Management L.P. decreased its position in shares of CVS Health Corporation (NYSE:CVS) by 10.4% during the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 69,000 shares of the pharmacy operator’s stock after selling 8,000 shares during the period. Olstein Capital Management L.P.’s holdings in CVS Health were worth $5,202,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of CVS. PDS Planning Inc boosted its holdings in shares of CVS Health by 4.5% during the third quarter. PDS Planning Inc now owns 4,994 shares of the pharmacy operator’s stock worth $376,000 after purchasing an additional 215 shares during the last quarter. SJS Investment Consulting Inc. lifted its position in CVS Health by 1,538.1% during the third quarter. SJS Investment Consulting Inc. now owns 688 shares of the pharmacy operator’s stock worth $52,000 after buying an additional 646 shares during the period. Econ Financial Services Corp purchased a new stake in CVS Health in the 3rd quarter valued at about $2,544,000. SOA Wealth Advisors LLC. increased its stake in shares of CVS Health by 36.9% during the 3rd quarter. SOA Wealth Advisors LLC. now owns 486 shares of the pharmacy operator’s stock valued at $37,000 after acquiring an additional 131 shares during the last quarter. Finally, Silver Oak Securities Incorporated lifted its holdings in shares of CVS Health by 3.8% during the 3rd quarter. Silver Oak Securities Incorporated now owns 4,340 shares of the pharmacy operator’s stock worth $327,000 after acquiring an additional 160 shares during the period. 80.66% of the stock is owned by hedge funds and other institutional investors.

CVS Health Stock Up 0.9%

Shares of NYSE CVS opened at $80.04 on Friday. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.63 and a current ratio of 0.83. CVS Health Corporation has a 1 year low of $44.14 and a 1 year high of $85.15. The stock’s 50-day simple moving average is $78.67 and its 200-day simple moving average is $73.37. The firm has a market cap of $101.61 billion, a price-to-earnings ratio of 210.64, a PEG ratio of 0.73 and a beta of 0.48.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.24. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The firm had revenue of $102.87 billion during the quarter, compared to analyst estimates of $98.85 billion. During the same quarter last year, the firm earned $1.09 EPS. CVS Health’s quarterly revenue was up 7.8% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. As a group, equities analysts anticipate that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on CVS shares. UBS Group restated an “outperform” rating on shares of CVS Health in a report on Wednesday, December 10th. Morgan Stanley boosted their price objective on shares of CVS Health from $89.00 to $93.00 and gave the company an “overweight” rating in a research note on Wednesday, December 10th. Robert W. Baird upped their price objective on CVS Health from $82.00 to $92.00 and gave the stock an “outperform” rating in a report on Wednesday, December 10th. Jefferies Financial Group lifted their price objective on CVS Health from $92.00 to $98.00 in a research note on Thursday, October 30th. Finally, Raymond James Financial lifted their target price on shares of CVS Health from $75.00 to $90.00 in a report on Friday, October 31st. Two research analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $94.67.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.